首頁 > 市場調查報告書 > 汽車工業

運輸/物流

市場調查報告書

商品編碼

1623048

全球醫藥物流市場規模：依物流類型、按流程、按應用、按地區、範圍及預測

Global Pharmaceutical Logistics Market Size By Type of Logistics, By Procedure, By Application, By Geographic Scope And Forecast

出版日期: 2024年07月31日 | 出版商:

Verified Market Research | 英文 202 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

醫藥物流市場規模及預測

預計2024年醫藥物流市場規模將達到1659.4億美元，預計2024年至2031年期間的複合年增長率為12.61%，到2031年將達到4291.1億美元。醫藥物流是醫療保健供應鏈的重要組成部分，涵蓋藥品從製造商到最終用戶的運輸、儲存和分銷。該專業確保藥品（包括處方藥、非處方藥、疫苗和生物製劑）安全、有效率地運送，並符合嚴格的監管標準。由於這些產品的敏感性，保持整個供應鏈的完整性、安全性和法規遵循至關重要。

醫藥物流的一個關鍵功能是運輸和儲存藥品製造原料，例如活性藥物成分 (API) 和賦形劑。有效的物流管理對於維持這些成分（尤其是溫度敏感物品）的品質和效力至關重要。

此外，對個人化醫療和生物製劑的日益關注將對醫藥物流的未來產生重大影響。個人化醫療根據每位患者的特徵制定治療方案，因此需要提供小劑量的客製化藥物。

全球醫學流市場動態

主要市場驅動因子

不斷成長的製藥業和全球藥品銷售：

製藥業的擴張和全球藥品銷售額的增加推動了對高效物流解決方案的需求。根據 Verified Market Research 的數據，製藥製造設備市場規模預計在 2023 年達到 139.5 億美元，預計到 2031 年將達到 224.1 億美元。

對溫度敏感的藥品和生物製藥數量不斷增加：

對溫度敏感的藥品和生物製藥的生產和分銷的不斷增加推動了對專業冷鏈物流的需求。根據 Verified Market Research 的數據，2023 年生物製藥市場規模價值為 4,138.3 億美元，預計到 2031 年將達到 6,746.6 億美元，2024 年至 2031 年的複合年增長率為 6.30%。

醫藥產業電子商務的成長：

疫情加速了電子商務的快速成長，推動了對高效最後一哩配送和直達患者的物流解決方案的需求。在美國，2020 年健康、個人護理和美容產品的電子商務銷售額成長了 32.4%，達到 721 億美元（美國人口普查局，2021 年）。

主要問題

嚴格的監理要求：

醫藥物流供應商必須遵守嚴格的規定，以確保產品品質和安全。歐盟每年進行約200次良好經銷規範（GDP）檢查，不合規率為5%至15%。

過熱和產品損壞：

在整個供應鏈中維持適當的溫度控制是一項關鍵課題，可能會導致產品損壞和經濟損失。據估計，由於運輸程序不正確，25%的疫苗在到達目的地時已經變質，造成每年341億美元的損失（世界衛生組織，2020年）。

營運成本和基礎設施需求高：

由於專用設備、倉儲設施和運輸成本高昂，醫藥物流市場面臨課題。建造一個藥品級倉庫的平均成本估計為每平方英尺 250-350 美元，明顯高於每平方英尺 50-65 美元的標準倉庫。

主要趨勢

數位化與先進技術的採用：

數位化正在改變醫藥物流產業，提高藥品安全性、生產力和整個流程。預計到 2025 年，物聯網在醫藥物流中的應用將使營運成本降低 25%，生產力提高 30%。

直接面向病患 (DTP) 和最後一哩配送模式的成長：

製藥業擴大採用直接面向患者的交付模式，尤其是在 COVID-19 疫情的推動下。

擴大生物製藥的冷鏈物流：

對溫度敏感的生物製藥和疫苗的興起正在推動專業化冷鏈物流的趨勢。

Pharmaceutical Logistics Market size was valued at USD 165.94 Billion in 2024 and is projected to reach USD 429.11 Billion by 2031 , growing at a CAGR of 12.61% from 2024 to 2031. Pharmaceutical logistics is a vital part of the healthcare supply chain, encompassing the transportation, storage, and distribution of pharmaceutical products from manufacturers to end users. This specialized field ensures that pharmaceuticals including prescription medications, over-the-counter drugs, vaccines, and biologics are delivered safely, efficiently, and in compliance with strict regulatory standards. Given the sensitivity of these products, maintaining integrity, security, and regulatory compliance throughout the supply chain is paramount.

A key function of pharmaceutical logistics involves transporting and storing raw materials for drug manufacturing, such as active pharmaceutical ingredients (APIs) and excipients. Effective logistics management is essential to preserve the quality and efficacy of these materials, especially since temperature control is critical for temperature-sensitive items.

Additionally, the rising focus on personalized medicine and biologics significantly influences the future of pharmaceutical logistics. Personalized medicine tailors treatment to individual patient characteristics, necessitating the transport of small, customized quantities of medications.

Global Pharmaceutical Logistics Market Dynamics

The key market dynamics that are shaping the global pharmaceutical logistics market include:

Key Market Drivers

Growing Pharmaceutical Industry and Global Drug Sales:

The expansion of the pharmaceutical industry and increasing global drug sales are driving the demand for efficient logistics solutions. According to Verified Market Research, the Pharmaceutical Manufacturing Equipment Market market size is estimated to be valued at USD 13.95 Billion in 2023 and is expected to reach a value of USD 22.41 Billion by 2031.

Rise in Temperature-Sensitive Pharmaceuticals and Biopharmaceuticals:

The increasing production and distribution of temperature-sensitive drugs and biopharmaceuticals are driving the need for specialized cold chain logistics. According to Verified Market Research, the Biopharmaceutical Market size was valued at USD 413.83 Billion in 2023 and is expected to reach USD 674.66 Billion by 2031, with a growing CAGR of 6.30% from 2024 to 2031.

E-commerce Growth in the Pharmaceutical Sector:

The rapid growth of e-commerce in the pharmaceutical sector, accelerated by the COVID-19 pandemic, is driving demand for efficient last-mile delivery and direct-to-patient logistics solutions. In the United States, e-commerce sales of health, personal care, and beauty products grew by 32.4% in 2020, reaching USD 72.1 Billion (U.S. Census Bureau, 2021).

Key Challenges

Stringent Regulatory Requirements:

The pharmaceutical logistics providers must adhere to strict regulations to maintain product quality and safety, which can be complex and costly to implement. In the EU, approximately 200 Good Distribution Practice (GDP) inspections are conducted annually, with non-compliance rates ranging from 5% to 15%.

Temperature Excursion and Product Spoilage:

Maintaining proper temperature control throughout the supply chain is crucial but challenging, leading to potential product spoilage and financial losses. It's estimated that 25% of vaccines reach their destination degraded because of incorrect shipping procedures, with losses amounting to USD 34.1 Billion annually (World Health Organization, 2020).

High Operating Costs and Infrastructure Requirements:

The pharmaceutical logistics market faces challenges due to the high costs associated with specialized equipment, storage facilities, and transportation. The average cost to build a pharmaceutical-grade warehouse is estimated at $250-$350 per square foot, significantly higher than standard warehouses at $50-$65 per square foot.

Key Trends

Adoption of Digitalization and Advanced Technologies:

Digitalization is transforming the pharmaceutical logistics industry, enhancing drug safety, productivity, and overall processes. Implementation of IoT in pharmaceutical logistics is projected to reduce operational costs by 25% and increase productivity by 30% by 2025.

Growth of Direct-to-Patient (DTP) and Last-Mile Delivery Models:

The pharmaceutical industry is increasingly adopting direct-to-patient delivery models, particularly accelerated by the COVID-19 pandemic.

Expansion of Cold Chain Logistics for Biopharmaceuticals:

With the rise of temperature-sensitive biopharmaceuticals and vaccines, there's a growing trend towards specialized cold chain logistics.

What's inside a VMR industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

Global Pharmaceutical Logistics Market Regional Analysis

Here is a more detailed regional analysis of the global pharmaceutical logistics market:

Europe

Europe substantially dominates the Global Pharmaceutical Logistics Market driven by the robust pharmaceutical industry and cross-border trade.

The significant increase in pharmaceutical trade across key European countries is a major driver for the market.

The European pharmaceutical market was valued at €277.7 billion in 2021, accounting for 23.4% of the global market (European Federation of Pharmaceutical Industries and Associations, EFPIA, 2022).

Pharmaceutical exports from the EU reached €474 billion in 2020, with Germany (€89.2 billion), Ireland (€79.1 billion), and Switzerland (€71.5 billion) being the top exporters (Eurostat, 2021).

Europe's stringent regulatory environment and high-quality standards drive the need for specialized pharmaceutical logistics services.

The European Medicines Agency (EMA) conducted 420 Good Manufacturing Practice (GMP) inspections in 2020, ensuring high-quality standards across the supply chain (EMA Annual Report, 2021).

The EU's Falsified Medicines Directive led to the implementation of a €1 billion Europe-wide medicine verification system in 2019, enhancing traceability and security in pharmaceutical logistics (European Medicines Verification Organisation, 2020).

The expansion of Europe's biopharmaceutical sector is driving demand for specialized cold chain logistics.

Asia Pacific

Asia Pacific is anticipated to witness the fastest growth in the global pharmaceutical logistics market during the forecast period owing to the rapid growth of the pharmaceutical industry in the region.

According to the China Chamber of Commerce for Import & Export of Medicines & Health Products, China's pharmaceutical exports reached USD 24.6 Billion in 2020, a year-on-year increase of 31%.

The World Health Organization reported that healthcare spending in the Asia Pacific region was expected to grow at an annual rate of 7.1% between 2020 and 2024, outpacing the global average of 5.4%.

According to the United Nations Economic and Social Commission for Asia and the Pacific (ESCAP), the number of people aged 65 and above in the region is projected to more than double from 535 million in 2019 to 1.3 billion by 2050.

Government initiatives to improve healthcare infrastructure and pharmaceutical distribution. China's "Healthy China 2030" plan aims to build a comprehensive healthcare system, with healthcare expenditure projected to reach USD 2.3 Trillion by 2030, according to the Chinese State Council.

The Indian government's "Pharma Vision 2020" initiative aims to make India a global leader in end-to-end drug manufacturing. As part of this, the government approved production-linked incentive (PLI) schemes worth ₹15,000 crore for the pharmaceutical sector in 2021.

Global Pharmaceutical Logistics Market: Segmentation Analysis

The Global Pharmaceutical Logistics Market is segmented based on Type of Logistics, Procedure, Application, And Geography.

Pharmaceutical Logistics Market, By Type of Logistics

Cold Chain Logistics
Non-Cold Logistics

Based on the Type of Logistics, the Global Pharmaceutical Logistics Market is bifurcated into Cold Chain Logistics, Non-Cold Logistics. The cold chain logistics segment dominates the global pharmaceutical logistics market. This dominance is primarily due to the rising demand for temperature-controlled products, such as COVID-19 vaccines, which require precise temperature management to preserve their efficacy. Stringent government regulations on maintaining proper temperatures for highly sensitive pharmaceuticals further boost the segment's growth.

Pharmaceutical Logistics Market, By Procedure

Picking
Storage
Retrieval Systems
Handling Systems

Based on the Procedure, the Global Pharmaceutical Logistics Market is bifurcated into Picking, Storage, Retrieval Systems, and Handling Systems. The storage segment dominates the global pharmaceutical logistics market owing to the growing demand for both generic and branded pharmaceutical products. The need for sophisticated storage facilities has surged to ensure the preservation of product efficacy post-production and to manage the seamless distribution through various channels to distributors and retailers.

Pharmaceutical Logistics Market, By Application

BioPharma
Chemical Pharma
Specialty Pharma

Based on the Application, the Global Pharmaceutical Logistics Market is bifurcated into BioPharma, Chemical Pharma, and Specialty Pharma. The Biopharma segment dominates the global pharmaceutical logistics market owing to its complex supply chains, which often involve multiple transportation modes and storage facilities. Maintaining precise temperature control throughout the supply chain is critical for ensuring product potency and safety. Additionally, strict regulatory compliance, including adherence to Good Distribution Practices (GDP), plays a crucial role in ensuring the safe and effective distribution of biopharma products, further reinforcing this segment's prominence in the pharmaceutical logistics market.

Pharmaceutical Logistics Market, By Geography

North America
Europe
Asia Pacific
Rest of the World

Based on Geography, the Global Pharmaceutical Logistics Market is classified into North America, Europe, Asia Pacific, and the Rest of the World. Europe substantially dominates the global pharmaceutical logistics market driven by the robust pharmaceutical industry and cross-border trade. The significant increase in pharmaceutical trade across key European countries is a major driver for the market. The European pharmaceutical market was valued at €277.7 billion in 2021, accounting for 23.4% of the global market (European Federation of Pharmaceutical Industries and Associations, EFPIA, 2022). Pharmaceutical exports from the EU reached €474 billion in 2020, with Germany (€89.2 billion), Ireland (€79.1 billion), and Switzerland (€71.5 billion) being the top exporters (Eurostat, 2021). Europe's stringent regulatory environment and high-quality standards drive the need for specialized pharmaceutical logistics services.

Key Players

The "Global Pharmaceutical Logistics Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are
Agility, Air Canada, CEVA Logistics, DB Schenker, Deutsche Post AG, FedEx, LifeConEx, Marken, United Parcel Service of America, Inc., and VersaCold Logistics Services.
This section offers in-depth analysis through a company overview, position analysis, the regional and industrial footprint of the company, and the ACE matrix for insightful competitive analysis. The section also provides an exhaustive analysis of the financial performances of mentioned players in the given market.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Global Pharmaceutical Logistics Market Key Developments

In January 2024, NX Netherlands announced the acquisition of IATA CEIV Pharma accreditation for their warehouse near Amsterdam Airport Schiphol. NX Netherlands has received IATA accreditation for pharmaceutical handling, ensuring safe and high-quality shipments.
In January 2024, Turkish Cargo announced the launch of breakthrough pharmaceutical logistics solutions, displaying their commitment to handling medicines and medical consignments perfectly. The company holds an IATA CEIV Pharma certificate, which ensures the safe shipment of pharmaceutical products.

1 INTRODUCTION OF GLOBAL PHARMACEUTICAL LOGISTICS MARKET

1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources

4 GLOBAL PHARMACEUTICAL LOGISTICS MARKET OUTLOOK

4.1 Overview
4.2 Market Dynamics
- 4.2.1 Drivers
- 4.2.2 Restraints
- 4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis

5 GLOBAL PHARMACEUTICAL LOGISTICS MARKET, BY TYPE OF LOGISTICS

5.1 Overview
5.2 Sea freight
5.3 Airfreight
5.4 Overland
5.5 Integrated logistics

6 GLOBAL PHARMACEUTICAL LOGISTICS MARKET, BY PROCEDURE

6.1 Overview
6.2 Picking
6.3 Storage
6.4 Retrieval systems
6.5 Handling systems

7 GLOBAL PHARMACEUTICAL LOGISTICS MARKET, BY APPLICATION

7.1 Overview
7.2 Bio Pharma
7.3 Chemical Pharma
7.4 Specialty Pharma

8 GLOBAL PHARMACEUTICAL LOGISTICS MARKET, BY GEOGRAPHY

8.1 Overview
8.2 North America
- 8.2.1 U.S.
- 8.2.2 Canada
- 8.2.3 Mexico
8.3 Europe
- 8.3.1 Germany
- 8.3.2 U.K.
- 8.3.3 France
- 8.3.4 Rest of Europe
8.4 Asia Pacific
- 8.4.1 China
- 8.4.2 Japan
- 8.4.3 India
- 8.4.4 Rest of Asia Pacific
8.5 Rest of the World
- 8.5.1 Latin America
- 8.5.2 Middle East and Africa

9 GLOBAL PHARMACEUTICAL LOGISTICS MARKET COMPETITIVE LANDSCAPE

9.1 Overview
9.2 Company Market Ranking
9.3 Key Development Strategies

10 COMPANY PROFILES

10.1 Agility
- 10.1.1 Overview
- 10.1.2 Financial Performance
- 10.1.3 Product Outlook
- 10.1.4 Key Developments
10.2 Air Canada
- 10.2.1 Overview
- 10.2.2 Financial Performance
- 10.2.3 Product Outlook
- 10.2.4 Key Developments
10.3 CEVA Logistics
- 10.3.1 Overview
- 10.3.2 Financial Performance
- 10.3.3 Product Outlook
- 10.3.4 Key Developments
10.4 DB Schenker
- 10.4.1 Overview
- 10.4.2 Financial Performance
- 10.4.3 Product Outlook
- 10.4.4 Key Developments
10.5 Deutsche Post AG
- 10.5.1 Overview
- 10.5.2 Financial Performance
- 10.5.3 Product Outlook
- 10.5.4 Key Developments
10.6 FedEx
- 10.6.1 Overview
- 10.6.2 Financial Performance
- 10.6.3 Product Outlook
- 10.6.4 Key Developments
10.7 LifeConEx
- 10.7.1 Overview
- 10.7.2 Financial Performance
- 10.7.3 Product Outlook
- 10.7.4 Key Developments
10.8 Marken
- 10.8.1 Overview
- 10.8.2 Financial Performance
- 10.8.3 Product Outlook
- 10.8.4 Key Developments
10.9 United Parcel Service of America, Inc.
- 10.9.1 Overview
- 10.9.2 Financial Performance
- 10.9.3 Product Outlook
- 10.9.4 Key Developments
10.10 VersaCold Logistics Services
- 10.10.1 Overview
- 10.10.2 Financial Performance
- 10.10.3 Product Outlook
- 10.10.4 Key Developments